Vimarsana
Biggest News Aggregation in the World

Page 2 - Benjamin Solomon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Benjamin Solomon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Benjamin Solomon Today - Breaking & Trending Today

ALK Inhibitor Outperforms Adjuvant Chemotherapy for Resected Lung Cancer - Vimarsana News

ALK Inhibitor Outperforms Adjuvant Chemotherapy for Resected Lung Cancer

Adjuvant alectinib reduces disease-free survival hazard by 76%

Adjuvant Alectinib Bests Chemo in ALK-Positive NSCLC - Vimarsana News

Adjuvant Alectinib Bests Chemo in ALK-Positive NSCLC

Adjuvant alectinib can improve disease-free survival, when compared to adjuvant chemotherapy, in patients with ALK+ NSCLC.

Novel Oral Medication Reduces Risk of Death by 76% in Patients With ALK-Positive Lung Cancer - Vimarsana News

Novel Oral Medication Reduces Risk of Death by 76% in Patients With ALK-Positive Lung Cancer

The statistically significant and clinically meaningful improvement in disease-free survival is “practice-changing” and may represent a “paradigm shift” in treatment, according to experts.

Ben Carson Fast Facts - Vimarsana News

Ben Carson Fast Facts

CNN Editorial Research

Source: wicz.com
Closing ASCO: AstraZeneca's 'very special' meeting, more CAR-T survival data and Pfizer's PARP play - Vimarsana News

Closing ASCO: AstraZeneca's 'very special' meeting, more CAR-T survival data and Pfizer's PARP play

BioPharma